| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pathology, Rosewell Park Memorial Institute, New York State Department of Health, Buffalo, New York 14263
The natural history of breast cancer with respect to its progression from hormone dependence to autonomy was studied by successively transplanting the earliest possible form of a rat mammary adenocarcinoma in syngeneic rats and isolating sublines of this tumor manifesting new endocrinoglogical and other biological characteristics over a period of 15 years. The original, fully mammotropin-dependent tumor MT-W9, whose growth is dependent entirely on pharmacological levels of mammotropin supplied by an extraneous source, gave rise to an estrogen-dependent variant, MT-W9A. This MT-W9A grows only in normal adult female hosts and regresses promptly upon oophorectomy. Subsequently, this tumor produced a subline, the fully autonomous MT-W9B, which grows well in any syngeneic rats regardless of their hormonal status. The third subline derived from the autonomous tumor was designated MT-W9C, the androgen-responsive line, because it grows better in male than in female rats. Having reversed its original female preference, it might also be characterized as reversely responsive. Chromosomal analysis of these 4 tumors disclosed 4 distinct stem cell lines, but each tumor also contained small numbers of cells from other stem lines. The progression from mammotropin dependence to androgen responsiveness in this mammary tumor system seems to have been accomplished by merely shifting from 1 stem line to another in an orderly sequence, and it appears to be an irreversible process. In addition to the hormone dependency, the progression of the tumor is accompanied by a gradual increase of cachexia-producing effects on the host that may be related to the immunogenicity of tumor cells. These 4 distinct hormonal characteristics encompass the entire known spectrum of breast cancer in man and animals with the exception of the metastasizing property. These tumors are being studied by many investigators and are maintained vertically and horizontally in syngeneic rats by us. The hormonal and cytogenetic characteristics of each stem cell line have been stable for over a decade.
1 This work was supported in part by Grant P-389 from the American Cancer Society and Contract N01-CB-23864 from the Breast Cancer Program Coordinating Branch, Division of Cancer Biology and Diagnosis, National Cancer Institue.
2 Fulbright Fellow. Present address: Department of Pathology, Institute of Pediatrics, Medical Academy of Krakow, Poland.
Received 2/ 5/75. Accepted 5/ 1/75.
This article has been cited by other articles:
![]() |
D. M. Wiktor-Brown, H.-S. Kwon, Y. S. Nam, P. T. C. So, and B. P. Engelward Integrated one- and two-photon imaging platform reveals clonal expansion as a major driver of mutation load PNAS, July 29, 2008; 105(30): 10314 - 10319. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kiang, M King, H. Zhang, B. Kennedy, and N Wang Cyclic biological expression in mouse mammary tumors Science, April 2, 1982; 216(4541): 68 - 70. [Abstract] [PDF] |
||||
![]() |
P. Kahn, R. S. Simon, A. S. Klein, and S. Shin Tumor Formation by Transformed Cells in Nude Mice Cold Spring Harb Symp Quant Biol, January 1, 1980; 44(0): 695 - 702. [Abstract] [PDF] |
||||
![]() |
M Ip, R. Milholland, F Rosen, and U Kim Mammary cancer: selective action of the estrogen receptor complex Science, January 26, 1979; 203(4378): 361 - 363. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |